Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

AI reads cancer slides: could it spot hidden spread?

NCT ID NCT06517979

First seen Dec 01, 2025 · Last updated Jun 23, 2026 · Updated 26 times

Summary

This study is developing an artificial intelligence (AI) model to detect whether cancer has spread to lymph nodes by analyzing digital images of tissue slides. Researchers will compare the AI's accuracy to that of pathologists in 10,000 cancer patients. The goal is to see if AI can help make lymph node diagnosis faster and more reliable in everyday clinical practice.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CANCER are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Sun Yat-sen Memorial Hospital of Sun Yat-sen University

    RECRUITING

    Guangzhou, Guangdong, 510120, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

Artificial intelligence (AI)-based diagnostic model

What this could lead to

If successful, this AI tool could help pathologists detect cancer spread to lymph nodes faster and more accurately, potentially improving treatment decisions.

What could go wrong

This is a diagnostic study, not a treatment. The AI model may not perform as well in real-world settings as in lab tests, and it requires further validation before routine use.

Conditions

The condition(s) this trial relates to.

Lymphatic Metastasis metastatic malignant neoplasm in the lymph nodes neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.